Xeris Pharmaceuticals Inc (XERS) earnings · rev $291.8M
These earnings events as JSON? API free 100/dayXeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
This XERS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported XERS revenue for 2025-12-31 was $291.8M. Net income was $554.0K. Revenue was up 43.7% from 2024-12-31 to 2025-12-31. XERS currently screens at market cap $760.7M.
When the next XERS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 43.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full XERS research stays on the stock page; the tape stays on the quote page.
XERS earnings FAQ
What are XERS's latest revenue and net income?
Latest cached Xeris Pharmaceuticals Inc (XERS) revenue for Dec 31, 2025 was $291.8M. Net income was $554.0K. Statements: https://lician.com/financials/xers
What is XERS's latest diluted EPS?
Latest cached Xeris Pharmaceuticals Inc (XERS) diluted EPS for Dec 31, 2025 was $0.00.
What period does the latest XERS earnings print cover?
The latest cached Xeris Pharmaceuticals Inc (XERS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did XERS revenue change from the prior cached period?
Cached Xeris Pharmaceuticals Inc (XERS) revenue was up 43.7% from $203.1M (Dec 31, 2024) to $291.8M (Dec 31, 2025). Statements: https://lician.com/financials/xers
Where are XERS earnings listed?
Cached earnings facts for Xeris Pharmaceuticals Inc (XERS) are listed at https://lician.com/earnings/xers. Statements: https://lician.com/financials/xers
Not investment advice.